A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016
Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma? Source: Annual Congress 2013 –The best of paediatric asthma and allergy Year: 2013
The effects of oral care on FeNO measurement in asthmatic patients Source: International Congress 2014 – Airway biomarkers Year: 2014
Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014
The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma Source: Annual Congress 2013 –Preschool wheeze Year: 2013
Study of therapeutics effects of montelukast in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016